Technical Analysis for INBS - Intelligent Bio Solutions Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.40 | 1.45% | 0.02 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 1.45% | |
| Inside Day | Range Contraction | 1.45% | |
| Wide Bands | Range Expansion | 1.45% | |
| Gapped Up | Strength | 1.45% | |
| Down 3 Days in a Row | Weakness | 1.45% | |
| Down 4 Days in a Row | Weakness | 1.45% |
| Alert | Time |
|---|---|
| Possible NR7 | about 17 hours ago |
| 60 Minute Opening Range Breakout | about 19 hours ago |
| Fell Below Previous Day's Low | about 21 hours ago |
| Down 2 % | about 21 hours ago |
| Down 1% | about 22 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 05/09/2023
Intelligent Bio Solutions Inc. Description
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Biotechnology Diabetes Tumor Glucose Diagnostic Tests Monitoring Diabetes Management
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.7 |
| 52 Week Low | 1.0 |
| Average Volume | 218,727 |
| 200-Day Moving Average | 2.41 |
| 50-Day Moving Average | 1.65 |
| 20-Day Moving Average | 1.54 |
| 10-Day Moving Average | 1.60 |
| Average True Range | 0.17 |
| RSI (14) | 43.50 |
| ADX | 18.21 |
| +DI | 20.06 |
| -DI | 23.75 |
| Chandelier Exit (Long, 3 ATRs) | 1.49 |
| Chandelier Exit (Short, 3 ATRs) | 1.82 |
| Upper Bollinger Bands | 1.85 |
| Lower Bollinger Band | 1.24 |
| Percent B (%b) | 0.27 |
| BandWidth | 39.82 |
| MACD Line | -0.03 |
| MACD Signal Line | 0.00 |
| MACD Histogram | -0.0232 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.48 | ||||
| Resistance 3 (R3) | 1.47 | 1.43 | 1.46 | ||
| Resistance 2 (R2) | 1.43 | 1.41 | 1.44 | 1.46 | |
| Resistance 1 (R1) | 1.42 | 1.40 | 1.43 | 1.43 | 1.45 |
| Pivot Point | 1.38 | 1.38 | 1.39 | 1.39 | 1.38 |
| Support 1 (S1) | 1.37 | 1.36 | 1.38 | 1.38 | 1.35 |
| Support 2 (S2) | 1.33 | 1.35 | 1.34 | 1.34 | |
| Support 3 (S3) | 1.32 | 1.33 | 1.34 | ||
| Support 4 (S4) | 1.33 |
